Molecular Nanomedicines for Gene Therapy and Cancer Immunology
Nanomedicine is revolutionizing medicine by enabling the precise delivery of potent but fragile therapeutic agents, directly addressing the major hurdles of toxicity and inefficiency that plague conventional treatments, especially in complex fields like gene therapy and cancer immunotherapy. Our approach harnesses the power of chemistry through metal-coordination-based nanostructures—specifically Nanoscale Coordination Polymers (NCPs) and nanoscale Metal-Organic Frameworks (nMOFs)—to create a uniquely versatile platform. What sets us apart is the atomic-level precision afforded by coordination chemistry: it allows us to meticulously engineer particle size, surface charge, porosity, and stimuli-responsive behavior for optimal targeting, cellular uptake, and controlled release. Unlike viral vectors or lipid nanoparticles, NCPs and nMOFs offer unparalleled cargo capacity for diverse payloads (DNA, RNA, immunomodulators), exceptional stability, and the intrinsic ability to incorporate therapeutic metals or function as immunostimulants themselves. This chemistry-driven design enables us to co-deliver genetic material with immune-activating agents in a single, tunable particle, creating synergistic strategies to overcome immune evasion in tumors and precisely correct genetic defects, offering a truly distinctive and potent solution for next-generation therapies. Why we are special？ • Atomic-Level Precision: fundamental chemical control unique to coordination chemistry. • Meticulous Engineering: fine-tune critical properties (size, charge, porosity, responsiveness) for optimal performance. • Contrast with Conventional Systems: overcoming limitations of viral vectors/lipid nanoparticles. • Unparalleled Capacity & Stability: inorganic-organic hybrid structure. • Intrinsic Functionality: great potential of the metal nodes or framework for therapy (e.g., immuno-stimulation, catalysis). • Co-Delivery & Synergy: Stresses the core innovation – integrating gene therapy and immunotherapy payloads in one smart particle.
|
